Trial Profile
Herceptin [trastuzumab] and paclitaxel in locally advanced breast cancer with Her2 overexpression
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2005 New trial record.